The traditional methods of synthesizing 1,2-arylheteroaryl ethanes have long been plagued with challenges such as reliance on pre-functionalized synthons, lengthy synthetic routes, limited substrate compatibility, and demanding reaction conditions. However, the team at NUS led by Associate Professor Wu Jie has overcome these obstacles by introducing a new approach that leverages light to initiate the generation of aryl radicals from aryl sulfonium salts. These reactive intermediates then react with ethylene and heteroarenes molecules to form the desired chemical compound, paving the way for more efficient and streamlined synthesis processes.
Ethylene, a fundamental component of the global chemical industry, plays a key role as a primary feedstock in this innovative approach. With a production volume exceeding 223 million tons in 2022, ethylene serves as a crucial building block for the synthesis of 1,2-arylheteroaryl ethanes. Additionally, arenes and heteroarenes molecules, which are widely available, are used as sources of aryl and heteroaryl chemical groups, further enhancing the modularity of the synthesis process.
The development of this modular synthesis approach has significant implications for the drug discovery and petrochemical industries. By enabling the modular and sustainable production of diverse molecular scaffolds, this method has the potential to revolutionize the way new drugs are developed and synthesized. The utilization of gaseous alkenes and the coupling of multiple fundamental components represent a major advancement in the field of organic synthesis, offering a more efficient and environmentally friendly alternative to traditional methods.
To add practicality to this synthetic protocol, a simple in-house built circulation flow system has been employed by the research team at NUS. This innovation demonstrates the feasibility and scalability of this approach, making it a promising tool for future drug development endeavors. As Associate Professor Wu Jie states, “Our long-standing interest in synthesizing valuable fine chemicals from fundamental feedstock chemicals, particularly natural gases, has led us to develop innovative, on-demand assembly strategies.” The future of drug discovery and pharmaceutical development looks brighter than ever with the introduction of this innovative modular synthesis approach.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
Leave a Reply